Novel targets in head and neck cancer: Should we be optimistic?

Gabriel S. Krigsfeld, Christine H. Chung

Research output: Contribution to journalArticle

Abstract

Head and neck squamous cell carcinomas have distinct mutation and copy-number profiles depending on human papilloma-virus status. Although several challenges remain in biomarker implementation and clinical trial feasibility, incorporating available genomic data will expedite the development of novel therapeutics and predictive biomarker-driven clinical trials.

Original languageEnglish (US)
Pages (from-to)495-497
Number of pages3
JournalClinical Cancer Research
Volume21
Issue number3
DOIs
StatePublished - Feb 1 2015

Fingerprint

Head and Neck Neoplasms
Papillomaviridae
Biomarkers
Clinical Trials
Mutation
Therapeutics
Carcinoma, squamous cell of head and neck

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Novel targets in head and neck cancer : Should we be optimistic? / Krigsfeld, Gabriel S.; Chung, Christine H.

In: Clinical Cancer Research, Vol. 21, No. 3, 01.02.2015, p. 495-497.

Research output: Contribution to journalArticle

Krigsfeld, Gabriel S. ; Chung, Christine H. / Novel targets in head and neck cancer : Should we be optimistic?. In: Clinical Cancer Research. 2015 ; Vol. 21, No. 3. pp. 495-497.
@article{ef34431662ef492fbae1f831b9c8b244,
title = "Novel targets in head and neck cancer: Should we be optimistic?",
abstract = "Head and neck squamous cell carcinomas have distinct mutation and copy-number profiles depending on human papilloma-virus status. Although several challenges remain in biomarker implementation and clinical trial feasibility, incorporating available genomic data will expedite the development of novel therapeutics and predictive biomarker-driven clinical trials.",
author = "Krigsfeld, {Gabriel S.} and Chung, {Christine H.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1158/1078-0432.CCR-14-1776",
language = "English (US)",
volume = "21",
pages = "495--497",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Novel targets in head and neck cancer

T2 - Should we be optimistic?

AU - Krigsfeld, Gabriel S.

AU - Chung, Christine H.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Head and neck squamous cell carcinomas have distinct mutation and copy-number profiles depending on human papilloma-virus status. Although several challenges remain in biomarker implementation and clinical trial feasibility, incorporating available genomic data will expedite the development of novel therapeutics and predictive biomarker-driven clinical trials.

AB - Head and neck squamous cell carcinomas have distinct mutation and copy-number profiles depending on human papilloma-virus status. Although several challenges remain in biomarker implementation and clinical trial feasibility, incorporating available genomic data will expedite the development of novel therapeutics and predictive biomarker-driven clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=84961290348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961290348&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-14-1776

DO - 10.1158/1078-0432.CCR-14-1776

M3 - Article

C2 - 25301846

AN - SCOPUS:84961290348

VL - 21

SP - 495

EP - 497

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 3

ER -